Superworth

Ceribell profit margin CBLL

Gross, operating and net profit as a share of revenue over the last twelve months, from 2024.

Net margin, 12 months
−64.7%
Operating margin, 12 months
−68.6%
Net margin on a year earlier
−0.9 pts
Peer median
12.8%

Over the twelve months to Jun 30, 2026, Ceribell kept −64.7% of its revenue as net profit, with an operating margin of −68.6% and a gross margin of 88.9%.

The median for 5 medical device stocks of a similar size is 12.8%.

Profit margin over time

GrossOperatingNet

Open the interactive chart, with overlays and comparisons

Fiscal year by fiscal year

Fiscal yearNet marginOperating marginGross margin
FY2025−60.0%−65.6%87.9%
FY2024−61.8%−60.7%86.7%
FY2023n/an/an/a

Quarter by quarter

QuarterEndedNet margin, 12 monthsChange on a yearOperating margin
Q2 FY26−64.7%−0.9 pts−68.6%
Q1 FY26−63.5%−1.0 pts−68.3%
Q4 FY25−60.0%+1.8 pts−65.6%
Q3 FY25−63.3%−3.1 pts−68.5%
Q2 FY25−63.8%−3.6 pts−67.1%
Q1 FY25−62.5%n/a−63.6%
Q4 FY24−61.8%n/a−60.7%
Q3 FY24−60.2%n/a−58.6%
Q2 FY24−60.2%n/a−59.6%
Q1 FY24n/an/an/a
Q4 FY23n/an/an/a
Q3 FY23n/an/an/a

Against its peers

Companies in Medical - Devices nearest Ceribell's size, closest first, today.

CompanyProfit margin
CBLLCeribell−64.7%
CNMDCONMED4.1%
TMDXTransMedics22.7%
ITGRInteger7.0%
LIVNLivaNova12.8%
ELMDElectromed15.3%
Peer median12.8%

Where Ceribell ranks

What the profit margin tells you

Profit as a share of revenue at three levels: gross (after making the product), operating (after running the business) and net (after everything, including tax and interest).

Compare within an industry. 10% is superb for a retailer and poor for a software company.

More on Ceribell

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.